Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
IntroductionThe dosimetric factors of radiotherapy have an acute impact on the host immune system during chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer (NSCLC). However, even after CRT, a substantial number of patients remain immunosuppressed with delayed lymphopenia. Therefo...
Main Authors: | Byung-Hee Kang, Xue Li, Jaeman Son, Changhoon Song, Hyun-Cheol Kang, Hak Jae Kim, Hong-Gyun Wu, Joo Ho Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.891221/full |
Similar Items
-
Neoadjuvant chemoradiotherapy induced lymphopenia in gastric cancer and associations with spleen dosimetry and survival outcomes
by: Ji-jin Wang, et al.
Published: (2023-05-01) -
Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
by: Peter S. N. van Rossum, et al.
Published: (2023-11-01) -
Lymphopenia in Esophageal Cancer: What Have We Learned?
by: Jia-Lin Wang, et al.
Published: (2021-03-01) -
Dosimetric predictors of treatment-related lymphopenia induced by palliative radiotherapy: predictive ability of dose-volume parameters based on body surface contour
by: Saito Tetsuo, et al.
Published: (2017-05-01) -
Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy
by: Xianyan Chen, et al.
Published: (2023-09-01)